nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—Crohn's disease	0.595	1	CiPCiCtD
Gemcitabine—SLC29A2—Mercaptopurine—Crohn's disease	0.131	0.406	CbGbCtD
Gemcitabine—SLC28A3—Mercaptopurine—Crohn's disease	0.113	0.351	CbGbCtD
Gemcitabine—SLC29A1—Mercaptopurine—Crohn's disease	0.075	0.233	CbGbCtD
Gemcitabine—ABCB1—Prednisone—Crohn's disease	0.00348	0.0108	CbGbCtD
Gemcitabine—Oligospermia—Mercaptopurine—Crohn's disease	0.0024	0.0529	CcSEcCtD
Gemcitabine—POLD1—mouth—Crohn's disease	0.00189	0.0628	CbGeAlD
Gemcitabine—Azoospermia—Mercaptopurine—Crohn's disease	0.00187	0.0411	CcSEcCtD
Gemcitabine—Azacitidine—DNMT3A—Crohn's disease	0.00139	0.506	CrCbGaD
Gemcitabine—Decitabine—DNMT3A—Crohn's disease	0.00135	0.494	CrCbGaD
Gemcitabine—Oligospermia—Mesalazine—Crohn's disease	0.0013	0.0287	CcSEcCtD
Gemcitabine—SLC28A1—digestive system—Crohn's disease	0.00126	0.0417	CbGeAlD
Gemcitabine—Alopecia reversible—Mesalazine—Crohn's disease	0.0012	0.0265	CcSEcCtD
Gemcitabine—RRM2—mouth—Crohn's disease	0.00117	0.0387	CbGeAlD
Gemcitabine—POLD1—skin of body—Crohn's disease	0.00105	0.0348	CbGeAlD
Gemcitabine—Azoospermia—Mesalazine—Crohn's disease	0.00101	0.0223	CcSEcCtD
Gemcitabine—Renal failure chronic—Mesalazine—Crohn's disease	0.00101	0.0223	CcSEcCtD
Gemcitabine—SLC28A3—mammalian vulva—Crohn's disease	0.000876	0.0291	CbGeAlD
Gemcitabine—Non-Hodgkin's lymphoma—Azathioprine—Crohn's disease	0.000857	0.0189	CcSEcCtD
Gemcitabine—Lymphoma—Azathioprine—Crohn's disease	0.000857	0.0189	CcSEcCtD
Gemcitabine—CDA—mammalian vulva—Crohn's disease	0.000857	0.0285	CbGeAlD
Gemcitabine—POLD1—lymphoid tissue—Crohn's disease	0.000848	0.0281	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—Crohn's disease	0.000847	0.0281	CbGeAlD
Gemcitabine—POLD1—digestive system—Crohn's disease	0.000838	0.0278	CbGeAlD
Gemcitabine—CMPK1—skin of body—Crohn's disease	0.000836	0.0277	CbGeAlD
Gemcitabine—SLC28A3—digestive system—Crohn's disease	0.000768	0.0255	CbGeAlD
Gemcitabine—CDA—lymphoid tissue—Crohn's disease	0.000761	0.0253	CbGeAlD
Gemcitabine—TYMS—Diflunisal—Mesalazine—Crohn's disease	0.000755	0.525	CbGdCrCtD
Gemcitabine—POLE—mammalian vulva—Crohn's disease	0.000714	0.0237	CbGeAlD
Gemcitabine—CMPK1—lymphoid tissue—Crohn's disease	0.000677	0.0225	CbGeAlD
Gemcitabine—CMPK1—digestive system—Crohn's disease	0.000668	0.0222	CbGeAlD
Gemcitabine—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.000651	0.0144	CcSEcCtD
Gemcitabine—RRM2—skin of body—Crohn's disease	0.000645	0.0214	CbGeAlD
Gemcitabine—POLE—lymphoid tissue—Crohn's disease	0.000634	0.021	CbGeAlD
Gemcitabine—POLE—digestive system—Crohn's disease	0.000626	0.0208	CbGeAlD
Gemcitabine—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00062	0.0137	CcSEcCtD
Gemcitabine—POLA1—mammalian vulva—Crohn's disease	0.000615	0.0204	CbGeAlD
Gemcitabine—RRM2—mammalian vulva—Crohn's disease	0.000588	0.0195	CbGeAlD
Gemcitabine—Lung infiltration—Mesalazine—Crohn's disease	0.000582	0.0128	CcSEcCtD
Gemcitabine—Interstitial pneumonia—Mesalazine—Crohn's disease	0.000565	0.0124	CcSEcCtD
Gemcitabine—RRM1—smooth muscle tissue—Crohn's disease	0.000543	0.018	CbGeAlD
Gemcitabine—RRM1—skin of body—Crohn's disease	0.000536	0.0178	CbGeAlD
Gemcitabine—Ulcer—Mercaptopurine—Crohn's disease	0.000532	0.0117	CcSEcCtD
Gemcitabine—RRM2—lymphoid tissue—Crohn's disease	0.000522	0.0173	CbGeAlD
Gemcitabine—RRM2—digestive system—Crohn's disease	0.000516	0.0171	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—Crohn's disease	0.000492	0.0163	CbGeAlD
Gemcitabine—RRM1—mammalian vulva—Crohn's disease	0.000489	0.0162	CbGeAlD
Gemcitabine—TYMS—skin of body—Crohn's disease	0.000486	0.0161	CbGeAlD
Gemcitabine—POLD1—lymph node—Crohn's disease	0.000478	0.0159	CbGeAlD
Gemcitabine—Nephropathy toxic—Mesalazine—Crohn's disease	0.000475	0.0105	CcSEcCtD
Gemcitabine—Transaminases increased—Mesalazine—Crohn's disease	0.000449	0.00989	CcSEcCtD
Gemcitabine—TYMS—mammalian vulva—Crohn's disease	0.000443	0.0147	CbGeAlD
Gemcitabine—Thrombocytosis—Mesalazine—Crohn's disease	0.000439	0.00967	CcSEcCtD
Gemcitabine—Sepsis—Mercaptopurine—Crohn's disease	0.000436	0.00962	CcSEcCtD
Gemcitabine—RRM1—lymphoid tissue—Crohn's disease	0.000434	0.0144	CbGeAlD
Gemcitabine—Hypomagnesaemia—Mesalazine—Crohn's disease	0.00043	0.00947	CcSEcCtD
Gemcitabine—CDA—lymph node—Crohn's disease	0.000429	0.0143	CbGeAlD
Gemcitabine—RRM1—digestive system—Crohn's disease	0.000428	0.0142	CbGeAlD
Gemcitabine—Interstitial lung disease—Azathioprine—Crohn's disease	0.000423	0.00933	CcSEcCtD
Gemcitabine—SLC29A2—lymph node—Crohn's disease	0.000401	0.0133	CbGeAlD
Gemcitabine—SLC29A1—mammalian vulva—Crohn's disease	0.000397	0.0132	CbGeAlD
Gemcitabine—TYMS—lymphoid tissue—Crohn's disease	0.000393	0.0131	CbGeAlD
Gemcitabine—TYMS—digestive system—Crohn's disease	0.000388	0.0129	CbGeAlD
Gemcitabine—Hepatotoxicity—Azathioprine—Crohn's disease	0.000388	0.00855	CcSEcCtD
Gemcitabine—Interstitial lung disease—Mesalazine—Crohn's disease	0.000386	0.0085	CcSEcCtD
Gemcitabine—CMPK1—lymph node—Crohn's disease	0.000382	0.0127	CbGeAlD
Gemcitabine—DCK—mammalian vulva—Crohn's disease	0.000379	0.0126	CbGeAlD
Gemcitabine—Dermatitis atopic—Mesalazine—Crohn's disease	0.000369	0.00813	CcSEcCtD
Gemcitabine—ABCC10—mammalian vulva—Crohn's disease	0.000362	0.012	CbGeAlD
Gemcitabine—POLE—lymph node—Crohn's disease	0.000358	0.0119	CbGeAlD
Gemcitabine—Pleural effusion—Mesalazine—Crohn's disease	0.000356	0.00785	CcSEcCtD
Gemcitabine—Hepatotoxicity—Mesalazine—Crohn's disease	0.000353	0.00779	CcSEcCtD
Gemcitabine—SLC29A1—lymphoid tissue—Crohn's disease	0.000353	0.0117	CbGeAlD
Gemcitabine—Neoplasm malignant—Azathioprine—Crohn's disease	0.000351	0.00773	CcSEcCtD
Gemcitabine—SLC29A1—digestive system—Crohn's disease	0.000348	0.0116	CbGeAlD
Gemcitabine—DCK—lymphoid tissue—Crohn's disease	0.000337	0.0112	CbGeAlD
Gemcitabine—DCK—digestive system—Crohn's disease	0.000333	0.011	CbGeAlD
Gemcitabine—ABCC10—lymphoid tissue—Crohn's disease	0.000321	0.0107	CbGeAlD
Gemcitabine—ABCC10—digestive system—Crohn's disease	0.000317	0.0105	CbGeAlD
Gemcitabine—Tenderness—Mesalazine—Crohn's disease	0.000313	0.00689	CcSEcCtD
Gemcitabine—Proteinuria—Mesalazine—Crohn's disease	0.000311	0.00685	CcSEcCtD
Gemcitabine—POLA1—lymph node—Crohn's disease	0.000308	0.0102	CbGeAlD
Gemcitabine—Vasculitis—Azathioprine—Crohn's disease	0.000307	0.00677	CcSEcCtD
Gemcitabine—Protein urine present—Mesalazine—Crohn's disease	0.000306	0.00675	CcSEcCtD
Gemcitabine—Bone disorder—Mesalazine—Crohn's disease	0.000302	0.00666	CcSEcCtD
Gemcitabine—Pancytopenia—Mercaptopurine—Crohn's disease	0.0003	0.0066	CcSEcCtD
Gemcitabine—Hypocalcaemia—Mesalazine—Crohn's disease	0.000298	0.00657	CcSEcCtD
Gemcitabine—RRM2—lymph node—Crohn's disease	0.000295	0.00978	CbGeAlD
Gemcitabine—Blood bilirubin increased—Mesalazine—Crohn's disease	0.000288	0.00636	CcSEcCtD
Gemcitabine—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.000288	0.00636	CcSEcCtD
Gemcitabine—Lymphopenia—Prednisone—Crohn's disease	0.000282	0.00622	CcSEcCtD
Gemcitabine—Stomatitis—Mercaptopurine—Crohn's disease	0.000274	0.00604	CcSEcCtD
Gemcitabine—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000273	0.00602	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000266	0.00586	CcSEcCtD
Gemcitabine—Influenza like illness—Mesalazine—Crohn's disease	0.000265	0.00584	CcSEcCtD
Gemcitabine—Skin exfoliation—Mesalazine—Crohn's disease	0.000261	0.00574	CcSEcCtD
Gemcitabine—Blood urea increased—Mesalazine—Crohn's disease	0.000258	0.00568	CcSEcCtD
Gemcitabine—Neuropathy—Mesalazine—Crohn's disease	0.000256	0.00565	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000249	0.00548	CcSEcCtD
Gemcitabine—RRM1—lymph node—Crohn's disease	0.000245	0.00812	CbGeAlD
Gemcitabine—Hepatic failure—Azathioprine—Crohn's disease	0.000242	0.00533	CcSEcCtD
Gemcitabine—Febrile neutropenia—Prednisone—Crohn's disease	0.00024	0.00529	CcSEcCtD
Gemcitabine—Immune system disorder—Mercaptopurine—Crohn's disease	0.000228	0.00503	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000228	0.00502	CcSEcCtD
Gemcitabine—Alopecia—Mercaptopurine—Crohn's disease	0.000223	0.00492	CcSEcCtD
Gemcitabine—TYMS—lymph node—Crohn's disease	0.000222	0.00737	CbGeAlD
Gemcitabine—Deafness—Mesalazine—Crohn's disease	0.000221	0.00488	CcSEcCtD
Gemcitabine—Hepatic failure—Mesalazine—Crohn's disease	0.00022	0.00486	CcSEcCtD
Gemcitabine—POLD1—Danazol—Prednisone—Crohn's disease	0.000213	0.148	CbGdCrCtD
Gemcitabine—Renal impairment—Mesalazine—Crohn's disease	0.000208	0.00459	CcSEcCtD
Gemcitabine—Dermatitis bullous—Mesalazine—Crohn's disease	0.000207	0.00457	CcSEcCtD
Gemcitabine—Anaemia—Mercaptopurine—Crohn's disease	0.000203	0.00448	CcSEcCtD
Gemcitabine—SLC29A1—lymph node—Crohn's disease	0.000199	0.0066	CbGeAlD
Gemcitabine—Leukopenia—Mercaptopurine—Crohn's disease	0.000197	0.00434	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000196	0.00432	CcSEcCtD
Gemcitabine—Dermatitis atopic—Prednisone—Crohn's disease	0.000195	0.0043	CcSEcCtD
Gemcitabine—Neuritis—Prednisone—Crohn's disease	0.000193	0.00426	CcSEcCtD
Gemcitabine—Face oedema—Mesalazine—Crohn's disease	0.000191	0.00422	CcSEcCtD
Gemcitabine—DCK—lymph node—Crohn's disease	0.00019	0.00631	CbGeAlD
Gemcitabine—Arthralgia—Mercaptopurine—Crohn's disease	0.000187	0.00412	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000186	0.0041	CcSEcCtD
Gemcitabine—Blood creatinine increased—Mesalazine—Crohn's disease	0.000186	0.00409	CcSEcCtD
Gemcitabine—Liver function test abnormal—Mesalazine—Crohn's disease	0.000183	0.00403	CcSEcCtD
Gemcitabine—ABCC10—lymph node—Crohn's disease	0.000181	0.00601	CbGeAlD
Gemcitabine—Oedema—Mercaptopurine—Crohn's disease	0.000179	0.00395	CcSEcCtD
Gemcitabine—Pancytopenia—Azathioprine—Crohn's disease	0.000178	0.00393	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000178	0.00393	CcSEcCtD
Gemcitabine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000176	0.00387	CcSEcCtD
Gemcitabine—Petechiae—Prednisone—Crohn's disease	0.000175	0.00387	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000175	0.00385	CcSEcCtD
Gemcitabine—Skin disorder—Mercaptopurine—Crohn's disease	0.000174	0.00384	CcSEcCtD
Gemcitabine—Influenza—Mesalazine—Crohn's disease	0.000171	0.00377	CcSEcCtD
Gemcitabine—Anorexia—Mercaptopurine—Crohn's disease	0.000171	0.00377	CcSEcCtD
Gemcitabine—Pneumonia—Azathioprine—Crohn's disease	0.000169	0.00372	CcSEcCtD
Gemcitabine—Bronchospasm—Mesalazine—Crohn's disease	0.000168	0.00371	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000166	0.00366	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000163	0.0036	CcSEcCtD
Gemcitabine—Pancytopenia—Mesalazine—Crohn's disease	0.000163	0.00358	CcSEcCtD
Gemcitabine—Neutropenia—Mesalazine—Crohn's disease	0.00016	0.00353	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000158	0.00349	CcSEcCtD
Gemcitabine—Agranulocytosis—Azathioprine—Crohn's disease	0.000156	0.00345	CcSEcCtD
Gemcitabine—Decreased appetite—Mercaptopurine—Crohn's disease	0.000156	0.00344	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000155	0.00341	CcSEcCtD
Gemcitabine—Pneumonia—Mesalazine—Crohn's disease	0.000154	0.00338	CcSEcCtD
Gemcitabine—Ulcer—Prednisone—Crohn's disease	0.000153	0.00336	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000151	0.00334	CcSEcCtD
Gemcitabine—Haemoglobin—Azathioprine—Crohn's disease	0.000151	0.00333	CcSEcCtD
Gemcitabine—Haemorrhage—Azathioprine—Crohn's disease	0.00015	0.00332	CcSEcCtD
Gemcitabine—Renal failure—Mesalazine—Crohn's disease	0.00015	0.00331	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00015	0.0033	CcSEcCtD
Gemcitabine—Stomatitis—Mesalazine—Crohn's disease	0.000149	0.00328	CcSEcCtD
Gemcitabine—TYMS—One Carbon Metabolism—DNMT3A—Crohn's disease	0.000149	0.0419	CbGpPWpGaD
Gemcitabine—Vasculitis—Prednisone—Crohn's disease	0.000148	0.00326	CcSEcCtD
Gemcitabine—Sweating—Mesalazine—Crohn's disease	0.000146	0.00323	CcSEcCtD
Gemcitabine—Haematuria—Mesalazine—Crohn's disease	0.000146	0.00321	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000144	0.00318	CcSEcCtD
Gemcitabine—Agranulocytosis—Mesalazine—Crohn's disease	0.000142	0.00314	CcSEcCtD
Gemcitabine—Erythema multiforme—Azathioprine—Crohn's disease	0.000142	0.00314	CcSEcCtD
Gemcitabine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000142	0.00313	CcSEcCtD
Gemcitabine—Skin exfoliation—Prednisone—Crohn's disease	0.000138	0.00304	CcSEcCtD
Gemcitabine—Haemoglobin—Mesalazine—Crohn's disease	0.000138	0.00304	CcSEcCtD
Gemcitabine—Rhinitis—Mesalazine—Crohn's disease	0.000137	0.00303	CcSEcCtD
Gemcitabine—Fluid retention—Prednisone—Crohn's disease	0.000137	0.00302	CcSEcCtD
Gemcitabine—Haemorrhage—Mesalazine—Crohn's disease	0.000137	0.00302	CcSEcCtD
Gemcitabine—Pharyngitis—Mesalazine—Crohn's disease	0.000136	0.003	CcSEcCtD
Gemcitabine—Immune system disorder—Azathioprine—Crohn's disease	0.000136	0.003	CcSEcCtD
Gemcitabine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000136	0.00299	CcSEcCtD
Gemcitabine—Neuropathy—Prednisone—Crohn's disease	0.000136	0.00299	CcSEcCtD
Gemcitabine—Urinary tract disorder—Mesalazine—Crohn's disease	0.000135	0.00298	CcSEcCtD
Gemcitabine—Oedema peripheral—Mesalazine—Crohn's disease	0.000135	0.00298	CcSEcCtD
Gemcitabine—Chills—Azathioprine—Crohn's disease	0.000135	0.00298	CcSEcCtD
Gemcitabine—Connective tissue disorder—Mesalazine—Crohn's disease	0.000135	0.00297	CcSEcCtD
Gemcitabine—Arrhythmia—Azathioprine—Crohn's disease	0.000134	0.00296	CcSEcCtD
Gemcitabine—Urethral disorder—Mesalazine—Crohn's disease	0.000134	0.00296	CcSEcCtD
Gemcitabine—TYMS—Trans-sulfuration and one carbon metabolism—DNMT3A—Crohn's disease	0.000134	0.0376	CbGpPWpGaD
Gemcitabine—Alopecia—Azathioprine—Crohn's disease	0.000133	0.00293	CcSEcCtD
Gemcitabine—Erythema multiforme—Mesalazine—Crohn's disease	0.00013	0.00286	CcSEcCtD
Gemcitabine—Pulmonary oedema—Prednisone—Crohn's disease	0.000129	0.00283	CcSEcCtD
Gemcitabine—Cardiac disorder—Mesalazine—Crohn's disease	0.000127	0.0028	CcSEcCtD
Gemcitabine—Sepsis—Prednisone—Crohn's disease	0.000125	0.00276	CcSEcCtD
Gemcitabine—Angiopathy—Mesalazine—Crohn's disease	0.000124	0.00274	CcSEcCtD
Gemcitabine—Immune system disorder—Mesalazine—Crohn's disease	0.000124	0.00273	CcSEcCtD
Gemcitabine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000123	0.00272	CcSEcCtD
Gemcitabine—Chills—Mesalazine—Crohn's disease	0.000123	0.00271	CcSEcCtD
Gemcitabine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000123	0.00271	CcSEcCtD
Gemcitabine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000122	0.00268	CcSEcCtD
Gemcitabine—Alopecia—Mesalazine—Crohn's disease	0.000121	0.00267	CcSEcCtD
Gemcitabine—Anaemia—Azathioprine—Crohn's disease	0.000121	0.00267	CcSEcCtD
Gemcitabine—ABCB1—epithelium—Crohn's disease	0.00012	0.00399	CbGeAlD
Gemcitabine—Erythema—Mesalazine—Crohn's disease	0.000119	0.00263	CcSEcCtD
Gemcitabine—Malaise—Azathioprine—Crohn's disease	0.000118	0.0026	CcSEcCtD
Gemcitabine—Leukopenia—Azathioprine—Crohn's disease	0.000117	0.00258	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Prednisone—Crohn's disease	0.000116	0.00255	CcSEcCtD
Gemcitabine—Back pain—Mesalazine—Crohn's disease	0.000115	0.00254	CcSEcCtD
Gemcitabine—Vomiting—Mercaptopurine—Crohn's disease	0.000114	0.00251	CcSEcCtD
Gemcitabine—Rash—Mercaptopurine—Crohn's disease	0.000113	0.00249	CcSEcCtD
Gemcitabine—Dermatitis—Mercaptopurine—Crohn's disease	0.000113	0.00249	CcSEcCtD
Gemcitabine—Arthralgia—Azathioprine—Crohn's disease	0.000111	0.00246	CcSEcCtD
Gemcitabine—Myalgia—Azathioprine—Crohn's disease	0.000111	0.00246	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000111	0.00244	CcSEcCtD
Gemcitabine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000111	0.00244	CcSEcCtD
Gemcitabine—Anaemia—Mesalazine—Crohn's disease	0.00011	0.00243	CcSEcCtD
Gemcitabine—Discomfort—Azathioprine—Crohn's disease	0.00011	0.00243	CcSEcCtD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00011	0.0308	CbGpPWpGaD
Gemcitabine—Malaise—Mesalazine—Crohn's disease	0.000108	0.00237	CcSEcCtD
Gemcitabine—Cardiac failure—Prednisone—Crohn's disease	0.000107	0.00237	CcSEcCtD
Gemcitabine—Leukopenia—Mesalazine—Crohn's disease	0.000107	0.00235	CcSEcCtD
Gemcitabine—Nausea—Mercaptopurine—Crohn's disease	0.000107	0.00235	CcSEcCtD
Gemcitabine—Infection—Azathioprine—Crohn's disease	0.000106	0.00234	CcSEcCtD
Gemcitabine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000105	0.00231	CcSEcCtD
Gemcitabine—ABCB1—mammalian vulva—Crohn's disease	0.000104	0.00346	CbGeAlD
Gemcitabine—Cough—Mesalazine—Crohn's disease	0.000104	0.00229	CcSEcCtD
Gemcitabine—Skin disorder—Azathioprine—Crohn's disease	0.000104	0.00229	CcSEcCtD
Gemcitabine—Hypertension—Mesalazine—Crohn's disease	0.000103	0.00227	CcSEcCtD
Gemcitabine—Chest pain—Mesalazine—Crohn's disease	0.000102	0.00224	CcSEcCtD
Gemcitabine—Myalgia—Mesalazine—Crohn's disease	0.000102	0.00224	CcSEcCtD
Gemcitabine—Arthralgia—Mesalazine—Crohn's disease	0.000102	0.00224	CcSEcCtD
Gemcitabine—Face oedema—Prednisone—Crohn's disease	0.000101	0.00223	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000101	0.00222	CcSEcCtD
Gemcitabine—Discomfort—Mesalazine—Crohn's disease	0.0001	0.00221	CcSEcCtD
Gemcitabine—Hypotension—Azathioprine—Crohn's disease	9.99e-05	0.0022	CcSEcCtD
Gemcitabine—SLC28A1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	9.91e-05	0.0279	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	9.74e-05	0.00215	CcSEcCtD
Gemcitabine—Oedema—Mesalazine—Crohn's disease	9.73e-05	0.00215	CcSEcCtD
Gemcitabine—Anaphylactic shock—Mesalazine—Crohn's disease	9.73e-05	0.00215	CcSEcCtD
Gemcitabine—Infection—Mesalazine—Crohn's disease	9.67e-05	0.00213	CcSEcCtD
Gemcitabine—Nervous system disorder—Mesalazine—Crohn's disease	9.55e-05	0.0021	CcSEcCtD
Gemcitabine—Hypokalaemia—Prednisone—Crohn's disease	9.54e-05	0.0021	CcSEcCtD
Gemcitabine—Thrombocytopenia—Mesalazine—Crohn's disease	9.53e-05	0.0021	CcSEcCtD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	9.48e-05	0.0267	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	9.48e-05	0.0267	CbGpPWpGaD
Gemcitabine—Skin disorder—Mesalazine—Crohn's disease	9.46e-05	0.00208	CcSEcCtD
Gemcitabine—Hyperhidrosis—Mesalazine—Crohn's disease	9.41e-05	0.00207	CcSEcCtD
Gemcitabine—Anorexia—Mesalazine—Crohn's disease	9.28e-05	0.00205	CcSEcCtD
Gemcitabine—ABCB1—lymphoid tissue—Crohn's disease	9.27e-05	0.00308	CbGeAlD
Gemcitabine—Alanine aminotransferase increased—Prednisone—Crohn's disease	9.24e-05	0.00204	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Azathioprine—Crohn's disease	9.23e-05	0.00203	CcSEcCtD
Gemcitabine—ABCB1—digestive system—Crohn's disease	9.16e-05	0.00304	CbGeAlD
Gemcitabine—Hypotension—Mesalazine—Crohn's disease	9.1e-05	0.00201	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	8.87e-05	0.00196	CcSEcCtD
Gemcitabine—Feeling abnormal—Azathioprine—Crohn's disease	8.81e-05	0.00194	CcSEcCtD
Gemcitabine—Insomnia—Mesalazine—Crohn's disease	8.8e-05	0.00194	CcSEcCtD
Gemcitabine—Paraesthesia—Mesalazine—Crohn's disease	8.74e-05	0.00193	CcSEcCtD
Gemcitabine—Dyspnoea—Mesalazine—Crohn's disease	8.68e-05	0.00191	CcSEcCtD
Gemcitabine—Somnolence—Mesalazine—Crohn's disease	8.65e-05	0.00191	CcSEcCtD
Gemcitabine—Neutropenia—Prednisone—Crohn's disease	8.47e-05	0.00187	CcSEcCtD
Gemcitabine—Decreased appetite—Mesalazine—Crohn's disease	8.46e-05	0.00187	CcSEcCtD
Gemcitabine—Body temperature increased—Azathioprine—Crohn's disease	8.45e-05	0.00186	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Mesalazine—Crohn's disease	8.4e-05	0.00185	CcSEcCtD
Gemcitabine—Fatigue—Mesalazine—Crohn's disease	8.39e-05	0.00185	CcSEcCtD
Gemcitabine—Constipation—Mesalazine—Crohn's disease	8.32e-05	0.00184	CcSEcCtD
Gemcitabine—Pain—Mesalazine—Crohn's disease	8.32e-05	0.00184	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	8.2e-05	0.0231	CbGpPWpGaD
Gemcitabine—Hyperglycaemia—Prednisone—Crohn's disease	8.17e-05	0.0018	CcSEcCtD
Gemcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	8.07e-05	0.0227	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Mesalazine—Crohn's disease	8.02e-05	0.00177	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Prednisone—Crohn's disease	7.96e-05	0.00175	CcSEcCtD
Gemcitabine—Myocardial infarction—Prednisone—Crohn's disease	7.92e-05	0.00175	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Prednisone—Crohn's disease	7.92e-05	0.00175	CcSEcCtD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	7.73e-05	0.0218	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	7.73e-05	0.0218	CbGpPWpGaD
Gemcitabine—Body temperature increased—Mesalazine—Crohn's disease	7.7e-05	0.0017	CcSEcCtD
Gemcitabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	7.51e-05	0.0211	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Prednisone—Crohn's disease	7.39e-05	0.0514	CbGdCrCtD
Gemcitabine—Diarrhoea—Azathioprine—Crohn's disease	7.31e-05	0.00161	CcSEcCtD
Gemcitabine—Haemoglobin—Prednisone—Crohn's disease	7.29e-05	0.00161	CcSEcCtD
Gemcitabine—Haemorrhage—Prednisone—Crohn's disease	7.25e-05	0.0016	CcSEcCtD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	7.19e-05	0.0202	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	7.19e-05	0.0202	CbGpPWpGaD
Gemcitabine—DCK—Diflorasone—Prednisone—Crohn's disease	7.17e-05	0.0499	CbGdCrCtD
Gemcitabine—Connective tissue disorder—Prednisone—Crohn's disease	7.12e-05	0.00157	CcSEcCtD
Gemcitabine—Asthenia—Mesalazine—Crohn's disease	6.98e-05	0.00154	CcSEcCtD
Gemcitabine—Pruritus—Mesalazine—Crohn's disease	6.89e-05	0.00152	CcSEcCtD
Gemcitabine—Vomiting—Azathioprine—Crohn's disease	6.8e-05	0.0015	CcSEcCtD
Gemcitabine—Rash—Azathioprine—Crohn's disease	6.74e-05	0.00149	CcSEcCtD
Gemcitabine—Dermatitis—Azathioprine—Crohn's disease	6.73e-05	0.00148	CcSEcCtD
Gemcitabine—Headache—Azathioprine—Crohn's disease	6.7e-05	0.00148	CcSEcCtD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	6.68e-05	0.0188	CbGpPWpGaD
Gemcitabine—Diarrhoea—Mesalazine—Crohn's disease	6.66e-05	0.00147	CcSEcCtD
Gemcitabine—Angiopathy—Prednisone—Crohn's disease	6.58e-05	0.00145	CcSEcCtD
Gemcitabine—Immune system disorder—Prednisone—Crohn's disease	6.55e-05	0.00144	CcSEcCtD
Gemcitabine—Arrhythmia—Prednisone—Crohn's disease	6.48e-05	0.00143	CcSEcCtD
Gemcitabine—Alopecia—Prednisone—Crohn's disease	6.41e-05	0.00141	CcSEcCtD
Gemcitabine—Nausea—Azathioprine—Crohn's disease	6.35e-05	0.0014	CcSEcCtD
Gemcitabine—Erythema—Prednisone—Crohn's disease	6.31e-05	0.00139	CcSEcCtD
Gemcitabine—Vomiting—Mesalazine—Crohn's disease	6.19e-05	0.00136	CcSEcCtD
Gemcitabine—Rash—Mesalazine—Crohn's disease	6.14e-05	0.00135	CcSEcCtD
Gemcitabine—Dermatitis—Mesalazine—Crohn's disease	6.13e-05	0.00135	CcSEcCtD
Gemcitabine—Headache—Mesalazine—Crohn's disease	6.1e-05	0.00134	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—Crohn's disease	6e-05	0.0417	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—Crohn's disease	5.92e-05	0.0412	CbGdCrCtD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	5.91e-05	0.0166	CbGpPWpGaD
Gemcitabine—TYMS—Triamcinolone—Prednisone—Crohn's disease	5.86e-05	0.0407	CbGdCrCtD
Gemcitabine—Ill-defined disorder—Prednisone—Crohn's disease	5.86e-05	0.00129	CcSEcCtD
Gemcitabine—Anaemia—Prednisone—Crohn's disease	5.83e-05	0.00129	CcSEcCtD
Gemcitabine—Nausea—Mesalazine—Crohn's disease	5.78e-05	0.00127	CcSEcCtD
Gemcitabine—Malaise—Prednisone—Crohn's disease	5.69e-05	0.00125	CcSEcCtD
Gemcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	5.6e-05	0.0158	CbGpPWpGaD
Gemcitabine—Hypertension—Prednisone—Crohn's disease	5.45e-05	0.0012	CcSEcCtD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.45e-05	0.0153	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Prednisone—Crohn's disease	5.4e-05	0.0376	CbGdCrCtD
Gemcitabine—Arthralgia—Prednisone—Crohn's disease	5.37e-05	0.00118	CcSEcCtD
Gemcitabine—Myalgia—Prednisone—Crohn's disease	5.37e-05	0.00118	CcSEcCtD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	5.36e-05	0.0151	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	5.36e-05	0.0151	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	5.34e-05	0.00118	CcSEcCtD
Gemcitabine—Discomfort—Prednisone—Crohn's disease	5.31e-05	0.00117	CcSEcCtD
Gemcitabine—ABCB1—lymph node—Crohn's disease	5.23e-05	0.00174	CbGeAlD
Gemcitabine—Oedema—Prednisone—Crohn's disease	5.15e-05	0.00114	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisone—Crohn's disease	5.15e-05	0.00114	CcSEcCtD
Gemcitabine—Infection—Prednisone—Crohn's disease	5.12e-05	0.00113	CcSEcCtD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.06e-05	0.0143	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Prednisone—Crohn's disease	5.05e-05	0.00111	CcSEcCtD
Gemcitabine—Skin disorder—Prednisone—Crohn's disease	5e-05	0.0011	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisone—Crohn's disease	4.98e-05	0.0011	CcSEcCtD
Gemcitabine—Anorexia—Prednisone—Crohn's disease	4.91e-05	0.00108	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.82e-05	0.0136	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.82e-05	0.0136	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.82e-05	0.0136	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Prednisone—Crohn's disease	4.73e-05	0.0329	CbGdCrCtD
Gemcitabine—Musculoskeletal discomfort—Prednisone—Crohn's disease	4.69e-05	0.00103	CcSEcCtD
Gemcitabine—Insomnia—Prednisone—Crohn's disease	4.66e-05	0.00103	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisone—Crohn's disease	4.62e-05	0.00102	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	4.62e-05	0.013	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—CREM—Crohn's disease	4.57e-05	0.0129	CbGpPWpGaD
Gemcitabine—TYMS—Danazol—Prednisone—Crohn's disease	4.54e-05	0.0316	CbGdCrCtD
Gemcitabine—Decreased appetite—Prednisone—Crohn's disease	4.48e-05	0.000987	CcSEcCtD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.48e-05	0.0126	CbGpPWpGaD
Gemcitabine—Fatigue—Prednisone—Crohn's disease	4.44e-05	0.000979	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	4.42e-05	0.0125	CbGpPWpGaD
Gemcitabine—Constipation—Prednisone—Crohn's disease	4.4e-05	0.000971	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisone—Crohn's disease	4.24e-05	0.000936	CcSEcCtD
Gemcitabine—Body temperature increased—Prednisone—Crohn's disease	4.07e-05	0.000898	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.93e-05	0.0111	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.93e-05	0.0111	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	3.78e-05	0.0106	CbGpPWpGaD
Gemcitabine—Asthenia—Prednisone—Crohn's disease	3.7e-05	0.000815	CcSEcCtD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.65e-05	0.0103	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.65e-05	0.0103	CbGpPWpGaD
Gemcitabine—Pruritus—Prednisone—Crohn's disease	3.64e-05	0.000803	CcSEcCtD
Gemcitabine—Diarrhoea—Prednisone—Crohn's disease	3.52e-05	0.000777	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—PLA2G4F—Crohn's disease	3.5e-05	0.00987	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.43e-05	0.00967	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.43e-05	0.00967	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.4e-05	0.00956	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	3.34e-05	0.0094	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.32e-05	0.00935	CbGpPWpGaD
Gemcitabine—Vomiting—Prednisone—Crohn's disease	3.27e-05	0.000722	CcSEcCtD
Gemcitabine—Rash—Prednisone—Crohn's disease	3.25e-05	0.000716	CcSEcCtD
Gemcitabine—Dermatitis—Prednisone—Crohn's disease	3.24e-05	0.000715	CcSEcCtD
Gemcitabine—Headache—Prednisone—Crohn's disease	3.23e-05	0.000711	CcSEcCtD
Gemcitabine—Nausea—Prednisone—Crohn's disease	3.06e-05	0.000674	CcSEcCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3e-05	0.00845	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—MTMR3—Crohn's disease	2.98e-05	0.00839	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.77e-05	0.0078	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.72e-05	0.00767	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.72e-05	0.00767	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.57e-05	0.00725	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	2.47e-05	0.00694	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.45e-05	0.00689	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.42e-05	0.00681	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—FADS1—Crohn's disease	2.32e-05	0.00654	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.27e-05	0.00641	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GPX4—Crohn's disease	2.17e-05	0.00612	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PLA2G4F—Crohn's disease	2.16e-05	0.00609	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.14e-05	0.00602	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	2.13e-05	0.00599	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GCKR—Crohn's disease	2.1e-05	0.00591	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.92e-05	0.0054	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.87e-05	0.00527	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MTMR3—Crohn's disease	1.84e-05	0.00518	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—UBE2D1—Crohn's disease	1.8e-05	0.00506	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	1.79e-05	0.00505	CbGpPWpGaD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.73e-05	0.00488	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.7e-05	0.00478	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PLA2G4F—Crohn's disease	1.64e-05	0.00462	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.61e-05	0.00454	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.47e-05	0.00414	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—FADS1—Crohn's disease	1.43e-05	0.00404	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	1.4e-05	0.00394	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MTMR3—Crohn's disease	1.39e-05	0.00393	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	1.39e-05	0.00392	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	1.37e-05	0.00384	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PLA2G4F—Crohn's disease	1.35e-05	0.0038	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	1.34e-05	0.00378	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PLA2G4F—Crohn's disease	1.34e-05	0.00378	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GPX4—Crohn's disease	1.34e-05	0.00378	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GCKR—Crohn's disease	1.3e-05	0.00365	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL17A—Crohn's disease	1.3e-05	0.00365	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—UBE2D1—Crohn's disease	1.28e-05	0.0036	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PLA2G4F—Crohn's disease	1.26e-05	0.00355	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—UBE2D1—Crohn's disease	1.25e-05	0.00352	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—UBE2D1—Crohn's disease	1.24e-05	0.0035	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL12B—Crohn's disease	1.2e-05	0.00339	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.2e-05	0.00338	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—UBE2D1—Crohn's disease	1.2e-05	0.00338	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTMR3—Crohn's disease	1.15e-05	0.00323	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTMR3—Crohn's disease	1.14e-05	0.00321	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—FADS1—Crohn's disease	1.09e-05	0.00306	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.08e-05	0.00304	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTMR3—Crohn's disease	1.07e-05	0.00302	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GPX4—Crohn's disease	1.02e-05	0.00287	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.93e-06	0.0028	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GCKR—Crohn's disease	9.83e-06	0.00277	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	9.79e-06	0.00276	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	9.57e-06	0.0027	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	9.17e-06	0.00258	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—FADS1—Crohn's disease	8.95e-06	0.00252	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—FADS1—Crohn's disease	8.89e-06	0.0025	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PLA2G4F—Crohn's disease	8.85e-06	0.00249	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.81e-06	0.00248	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL10—Crohn's disease	8.8e-06	0.00248	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—UBE2D1—Crohn's disease	8.56e-06	0.00241	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GPX4—Crohn's disease	8.38e-06	0.00236	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—FADS1—Crohn's disease	8.36e-06	0.00235	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GPX4—Crohn's disease	8.33e-06	0.00235	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	8.29e-06	0.00233	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—UBE2D1—Crohn's disease	8.2e-06	0.00231	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ALB—Crohn's disease	8.19e-06	0.00231	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GCKR—Crohn's disease	8.09e-06	0.00228	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GCKR—Crohn's disease	8.04e-06	0.00226	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	7.94e-06	0.00224	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	7.85e-06	0.00221	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GPX4—Crohn's disease	7.83e-06	0.0022	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ALB—Crohn's disease	7.7e-06	0.00217	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GCKR—Crohn's disease	7.56e-06	0.00213	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTMR3—Crohn's disease	7.53e-06	0.00212	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ALB—Crohn's disease	6.68e-06	0.00188	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.11e-06	0.00172	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—FADS1—Crohn's disease	5.86e-06	0.00165	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—Crohn's disease	5.84e-06	0.00165	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.59e-06	0.00158	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	5.53e-06	0.00156	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GPX4—Crohn's disease	5.49e-06	0.00155	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.36e-06	0.00151	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GCKR—Crohn's disease	5.3e-06	0.00149	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	5.18e-06	0.00146	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.96e-06	0.0014	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.96e-06	0.0014	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	4.81e-06	0.00136	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	4.62e-06	0.0013	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—Crohn's disease	4.15e-06	0.00117	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—Crohn's disease	4.13e-06	0.00116	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—Crohn's disease	3.61e-06	0.00102	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.49e-06	0.000984	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—Crohn's disease	3.35e-06	0.000944	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—Crohn's disease	3.13e-06	0.000881	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.09e-06	0.00087	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—Crohn's disease	2.74e-06	0.00077	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.73e-06	0.000769	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—Crohn's disease	2.58e-06	0.000725	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—Crohn's disease	2.56e-06	0.000721	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.45e-06	0.00069	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—Crohn's disease	2.41e-06	0.000678	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTMR3—Crohn's disease	2.32e-06	0.000654	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—Crohn's disease	2.25e-06	0.000634	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—Crohn's disease	2.24e-06	0.000631	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—Crohn's disease	2.11e-06	0.000593	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FADS1—Crohn's disease	1.81e-06	0.000509	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPX4—Crohn's disease	1.69e-06	0.000477	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—Crohn's disease	1.69e-06	0.000475	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.65e-06	0.000466	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GCKR—Crohn's disease	1.64e-06	0.000461	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—Crohn's disease	1.48e-06	0.000416	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.11e-06	0.000313	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—Crohn's disease	5.21e-07	0.000147	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—Crohn's disease	4.56e-07	0.000128	CbGpPWpGaD
